new board, now new revenue, page-9

too right, i was a little slow getting to those ksxo oppies that went out the window at .002 last week. shame. would have liked to have averaged off to a round figure. got enough to make it very interestig if they get anywhere near the money.

no doubt in my mind this will be management's aim. if they are not aiming for a .20 shareprice come end of financial year they are kidding themselves. they've now had a long time to plan and implement the sales roll out. looking at their products and the ongoing revenue stream through diagnostic services they will only need to prove they are getting doctors on board through early sales and this will be re-rated accordingly.

the tech is so good and business model such a money spinner long term that i expect resmed or some other company in the related fields to take them out long before they get to expensive market cao wise. only needs to pop up to 50m market cap for the ops to be a multibagger from these levels.

but when are they going to push the button?